Logo image of U6Z.DE

URANIUM ENERGY CORP (U6Z.DE) Stock Fundamental Analysis

FRA:U6Z - US9168961038 - Common Stock

10.708 EUR
+0.61 (+6.02%)
Last: 9/10/2025, 4:56:12 PM
Fundamental Rating

3

Taking everything into account, U6Z scores 3 out of 10 in our fundamental rating. U6Z was compared to 63 industry peers in the Oil, Gas & Consumable Fuels industry. No worries on liquidiy or solvency for U6Z as it has an excellent financial health rating, but there are worries on the profitability. U6Z is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

U6Z had negative earnings in the past year.
In the past year U6Z has reported a negative cash flow from operations.
U6Z had negative earnings in 4 of the past 5 years.
In the past 5 years U6Z reported 4 times negative operating cash flow.
U6Z.DE Yearly Net Income VS EBIT VS OCF VS FCFU6Z.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

With a Return On Assets value of -7.51%, U6Z is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
U6Z has a Return On Equity of -8.48%. This is amonst the worse of the industry: U6Z underperforms 87.30% of its industry peers.
Industry RankSector Rank
ROA -7.51%
ROE -8.48%
ROIC N/A
ROA(3y)-0.75%
ROA(5y)-5.39%
ROE(3y)-0.89%
ROE(5y)-7.03%
ROIC(3y)N/A
ROIC(5y)N/A
U6Z.DE Yearly ROA, ROE, ROICU6Z.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

U6Z's Gross Margin of 36.62% is in line compared to the rest of the industry. U6Z outperforms 41.27% of its industry peers.
The Profit Margin and Operating Margin are not available for U6Z so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
U6Z.DE Yearly Profit, Operating, Gross MarginsU6Z.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

8

2. Health

2.1 Basic Checks

U6Z does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, U6Z has more shares outstanding
Compared to 5 years ago, U6Z has more shares outstanding
U6Z has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
U6Z.DE Yearly Shares OutstandingU6Z.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
U6Z.DE Yearly Total Debt VS Total AssetsU6Z.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

U6Z has an Altman-Z score of 27.00. This indicates that U6Z is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of U6Z (27.00) is better than 100.00% of its industry peers.
There is no outstanding debt for U6Z. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 27
ROIC/WACCN/A
WACC8.69%
U6Z.DE Yearly LT Debt VS Equity VS FCFU6Z.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

U6Z has a Current Ratio of 10.11. This indicates that U6Z is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 10.11, U6Z belongs to the best of the industry, outperforming 98.41% of the companies in the same industry.
U6Z has a Quick Ratio of 5.05. This indicates that U6Z is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of U6Z (5.05) is better than 95.24% of its industry peers.
Industry RankSector Rank
Current Ratio 10.11
Quick Ratio 5.05
U6Z.DE Yearly Current Assets VS Current LiabilitesU6Z.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

The earnings per share for U6Z have decreased strongly by -300.00% in the last year.
U6Z shows a strong growth in Revenue. In the last year, the Revenue has grown by 70.62%.
EPS 1Y (TTM)-300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
Revenue 1Y (TTM)70.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, U6Z will show a very strong growth in Earnings Per Share. The EPS will grow by 57.53% on average per year.
The Revenue is expected to grow by 61.60% on average over the next years. This is a very strong growth
EPS Next Y-354.5%
EPS Next 2Y26.33%
EPS Next 3Y80.84%
EPS Next 5Y57.53%
Revenue Next Year94.09%
Revenue Next 2Y48.94%
Revenue Next 3Y64.92%
Revenue Next 5Y61.6%

3.3 Evolution

U6Z.DE Yearly Revenue VS EstimatesU6Z.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
U6Z.DE Yearly EPS VS EstimatesU6Z.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.1 -0.1 0.2 -0.2 0.3

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for U6Z. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for U6Z. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
U6Z.DE Price Earnings VS Forward Price EarningsU6Z.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
U6Z.DE Per share dataU6Z.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as U6Z's earnings are expected to grow with 80.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.33%
EPS Next 3Y80.84%

0

5. Dividend

5.1 Amount

U6Z does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

URANIUM ENERGY CORP

FRA:U6Z (9/10/2025, 4:56:12 PM)

10.708

+0.61 (+6.02%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)06-02 2025-06-02/bmo
Earnings (Next)09-26 2025-09-26/amc
Inst Owners77.36%
Inst Owner ChangeN/A
Ins Owners1.81%
Ins Owner ChangeN/A
Market Cap4.76B
Analysts80
Price Target9.5 (-11.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.09%
PT rev (3m)3.63%
EPS NQ rev (1m)-33.33%
EPS NQ rev (3m)-566.67%
EPS NY rev (1m)-227.27%
EPS NY rev (3m)-227.27%
Revenue NQ rev (1m)-50%
Revenue NQ rev (3m)-43.33%
Revenue NY rev (1m)-5.8%
Revenue NY rev (3m)-15.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 83.61
P/FCF N/A
P/OCF N/A
P/B 6.26
P/tB 30.63
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.13
BVpS1.71
TBVpS0.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.51%
ROE -8.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.62%
FCFM N/A
ROA(3y)-0.75%
ROA(5y)-5.39%
ROE(3y)-0.89%
ROE(5y)-7.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 247.26%
Cap/Sales 8.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.11
Quick Ratio 5.05
Altman-Z 27
F-Score3
WACC8.69%
ROIC/WACCN/A
Cap/Depr(3y)135.76%
Cap/Depr(5y)103.6%
Cap/Sales(3y)511.99%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
EPS Next Y-354.5%
EPS Next 2Y26.33%
EPS Next 3Y80.84%
EPS Next 5Y57.53%
Revenue 1Y (TTM)70.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year94.09%
Revenue Next 2Y48.94%
Revenue Next 3Y64.92%
Revenue Next 5Y61.6%
EBIT growth 1Y-78.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-137.78%
EBIT Next 3Y83.01%
EBIT Next 5Y60.09%
FCF growth 1Y-316.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-292.66%
OCF growth 3YN/A
OCF growth 5YN/A